6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents

Pavla Perlíková, Petr Konečný, Petr Nauš, Jan Snášel, Ivan Votruba, Petr Džubák, Iva Pichová, Marián Hajdúch, Michal Hocek
  • MedChemComm, January 2013, Royal Society of Chemistry
  • DOI: 10.1039/c3md00232b

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Michal Hocek